Mechanism
CB2 receptor and PPARγ (dual agonist)
Assets acting on this target.
- Class
- semi-synthetic cannabinoquinone (cannabidiol-quinone derivative); dev codes VCE-004.8 / EHP-101
- Pathway
- Dual CB2/PPARγ receptor agonism, plus PP2A/B55α activation and prolyl-hydroxylase (PHD) inhibition driving HIF pathway activation; net anti-inflammatory, anti-fibrotic and pro-angiogenic effect being tested in peripheral arterial disease
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
1 of 1 assets